Methods of treating cns disorders
AssigneeForest Laboratories Holdings Limited
InventorsKelly PAPADAKIS, Nika ADHAM, Gary SAMORISKI
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating various CNS disorders, e.g., mania, bipolar disorder and schizophrenia, by administering NMDA receptor antagonists, alone or in combination with dopamine receptor antagonists.
Claims43
A method of treating a condition selected from mania and bipolar disorder comprising administering to a patient in need thereof a therapeutically effective amount of an NMDA receptor antagonist, or a pharmaceutically acceptable salt thereof.
A method of treating a condition selected from mania, bipolar disorder and schizophrenia, comprising administering to a patient in need thereof a therapeutically effective amount of an NMDA receptor antagonist, or a pharmaceutically acceptable salt thereof, and a compound of formula (I), or a pharmaceutically acceptable salt thereof:
- wherein
- R1 and R2 are each, independently hydrogen, alkyl, alkenyl, aryl, cycloalkyl, or aroyl, or R1 and R2 form a heterocyclic ring with the adjacent nitrogen atom;
- X is O or S;
- and
- n is 1 or 2.
A pharmaceutical composition comprising
- (i) an NMDA receptor antagonist,
- (ii) a compound of formula (I), or a pharmaceutically acceptable salt thereof:
- wherein
- R1 and R2 are each, independently hydrogen, alkyl, alkenyl, aryl, cycloalkyl, or aroyl, or R1 and R2 form a heterocyclic ring with the adjacent nitrogen atom;
- X is O or S;
- and
- n is 1 or 2;
- and pharmaceutically acceptable salts and solvates thereof, and
- (iii) a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.